CNS SPECIALIST / DIFFERENTIATED PRODUCTS / OUR PORTFOLIO
Comprehensive CNS Portfolio
Neuraxpharm has one of the most extensive product portfolios in CNS pharmaceuticals in Europe to offer patients
and medical specialists affordable cutting-edge CNS pharmaceuticals
-
Comprehensive marketed CNS portfolio tailored to the different European market needs
-
Unique molecules in the market
-
Added value dosage forms and strengths
-
Cross-country synergies in portfolio
-
CNS VALUE
ADDED MEDICINES
View
-
CNS
STANDARD GENERICS
View
-
CNS
CONSUMER HEALTHCARE
View
- Our strength comes from offering one of the most comprehensive product portfolios in CNS pharmaceuticals in Europe
- We offer a complete spectrum of therapeutic options in Epilepsy, Parkinson's, Psychosis / Schizophrenia, Depression and Alzheimer's as well as a growing portfolio in other CNS indications
- Our product portfolio includes >130 CNS molecules in the categories of Analgesics, Antidementia agents, Antidepressants, Antiepileptics, Antiparkinson agents, Antipsychotics, Anxiolytics/Hypnotics and other CNS categories
- We are experts in improving existing pharmaceutical forms and in upgrading new products. In some cases, new patient-friendly products and formulations are developed at the request of, and in close consultation with, medical specialists
- Our extensive portfolio includes not only high-turnover products and conventional pharmaceutical forms but, thanks to Neuraxpharm’s intense patient focus, we can also provide less popular preparations and offer products in a comprehensive, patient-friendly range of active substances in well-tolerated forms, along with a very wide range of dosages for personalised treatment
- It is part of Neuraxpharm’s very identity to be able to offer patients and medical specialists affordable cutting-edge CNS drugs
- Medicines are improved by innovative advancements in their pharmaceutical forms and by more practical dosing
- The integration of all the companies within Neuraxpharm allows us to establish both growth and cross-business synergies in many strategic aspects such as R&D, manufacturing, procurement, cross-licensing and geographical expansion